News
BerGenBio ASA the ("Company") hereby announces a fully underwritten rights issue with preferential subscription rights (the ...
Discover how Sera Prognostics' PreTRM test reduces neonatal risks, targets a vast preterm birth market, and offers investors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback